(Q48666474)

English

Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level.

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

darbepoetin alfa

0 references

1 reference

based on heuristic

inferred from title

author name string

Gaspar Esquerdo

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

Cristina Llorca

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

José Manuel Cervera

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

David Orts

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

Asunción Juárez

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

Alfredo Carrato

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

13

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

341-347

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

https://scigraph.springernature.com/pub.10.1007/s12094-011-0664-3

0 references

Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Applications of darbepoietin-alpha, a novel erythropoiesis-stimulating protein, in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Fatigue in cancer patients compared with fatigue in the general United States population.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0664-3

21 January 2018

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug therapy for the management of cancer related fatigue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer-related fatigue: guidelines for evaluation and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks

1 reference

https://pubmed.ncbi.nlm.nih.gov/21596663

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-011-0664-3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21596663

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48666474&oldid=1409442656"